Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,400
- Avg volume
- —
- Day's range
- $1.32 – $1.32
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Vector Science and Therapeutics Corp. develops precision biomechanical devices and active transdermal delivery systems for musculoskeletal regeneration. The company offers cGMP-manufactured Rx peptides for physicians and patients across sports, regenerative, and longevity medicine channels. It also provides VectorMist, a commercial precision therapeutic platform, as well as Valor, a delivery system and transdermal pl...
Show more
Vector Science and Therapeutics Corp. develops precision biomechanical devices and active transdermal delivery systems for musculoskeletal regeneration. The company offers cGMP-manufactured Rx peptides for physicians and patients across sports, regenerative, and longevity medicine channels. It also provides VectorMist, a commercial precision therapeutic platform, as well as Valor, a delivery system and transdermal platform. The company is based in Mequon, Wisconsin.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- (833) 832-8724
- Website
- https://vectorscience.co
- Address
- 12250 Corporate Parkway, Mequon, United States
Latest news
No headlines yet.
